|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 922.85 INR | -0.06% |
|
+4.91% | +22.80% |
| 05-28 | Supriya Lifescience Limited, Q4 2026 Earnings Call, May 28, 2026 | |
| 05-27 | Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 74.27B 779M 674M 630M 576M 1.09B 1.1B 7.39B 2.9B 37.16B 2.92B 2.86B 124B | P/E 2026 |
21.6x | P/E 2027 * | 30.9x |
|---|---|---|---|---|---|
| Enterprise Value | 74.27B 779M 674M 630M 576M 1.09B 1.1B 7.39B 2.9B 37.16B 2.92B 2.86B 124B | EV / Sales 2026 |
5.46x | EV / Sales 2027 * | 7.48x |
| Free-Float |
28.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supriya Lifescience Limited
| 1 day | -0.06% | ||
| 1 week | +4.91% | ||
| Current month | +6.44% | ||
| 1 month | +7.99% | ||
| 3 months | +30.59% | ||
| 6 months | +34.34% | ||
| Current year | +22.80% |
| 1 week | 876.45 |  | 951 |
| 1 month | 816.1 | | 951 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 234.9 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 34 | 01/08/2024 | |
| Chief Executive Officer | 36 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 26/03/2008 | |
| Director/Board Member | 41 | 01/06/2019 | |
| Director/Board Member | 36 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | +4.91% | +40.30% | +244.73% | 779M | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,098B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 631B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 438B | |
| +0.05% | +4.28% | +51.44% | +40.68% | 368B | |
| +0.47% | +2.15% | +32.56% | +40.21% | 298B | |
| +0.26% | +2.26% | +8.78% | +8.84% | 251B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 226B | |
| +1.17% | +0.67% | -4.01% | -50.10% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | +0.40% | +1,491.89% | +35.84% | +66.20% | 368.51B | |
| Weighted average by Cap. | +0.35% | +1,331.22% | +52.01% | +68.83% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.4B 88.07M 76.25M 71.27M 65.13M 123M 125M 836M 328M 4.2B 331M 323M 14B | 9.94B 104M 90.18M 84.29M 77.04M 145M 147M 988M 388M 4.97B 391M 383M 16.55B |
| Net income | 2B 20.98M 18.16M 16.98M 15.52M 29.24M 29.7M 199M 78.12M 1B 78.78M 77.06M 3.33B | 2.41B 25.26M 21.87M 20.44M 18.68M 35.2M 35.75M 240M 94.05M 1.21B 94.84M 92.77M 4.01B |
| Net Debt | - | - |
Employees
515
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | ₹922.85 | -0.06% | 240,832 |
| 07/08/26 | ₹923.45 | +3.66% | 234,139 |
| 06/08/26 | ₹890.85 | -2.49% | 469,337 |
| 05/08/26 | ₹913.60 | +2.92% | 279,750 |
| 04/08/26 | ₹887.65 | +0.91% | 192,508 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
